关注
Ashique Rafique
Ashique Rafique
Regeneron Pharmaceutical
在 regeneron.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
N Papadopoulos, J Martin, Q Ruan, A Rafique, MP Rosconi, E Shi, ...
Angiogenesis 15, 171-185, 2012
11952012
Kyratsous CA
J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ...
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 …, 2020
10622020
Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant
L Yurkovetskiy, X Wang, KE Pascal, C Tomkins-Tinch, TP Nyalile, Y Wang, ...
Cell 183 (3), 739-751. e8, 2020
10382020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ...
Science 369 (6506), 1010-1014, 2020
9892020
High affinity antibodies to human IL-6 receptor
S Stevens, TT Huang, JH Martin, JL Fairhurst, A Rafique, E Smith, ...
US Patent 7,582,298, 2009
4412009
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering
S Davis, N Papadopoulos, TH Aldrich, PC Maisonpierre, T Huang, ...
Nature structural biology 10 (1), 38-44, 2003
3272003
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
A Le Floc’h, J Allinne, K Nagashima, G Scott, D Birchard, S Asrat, Y Bai, ...
Allergy 75 (5), 1188-1204, 2020
2732020
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
V Gusarova, CA Alexa, Y Wang, A Rafique, JH Kim, D Buckler, IJ Mintah, ...
Journal of lipid research 56 (7), 1308-1317, 2015
2112015
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
JM Orengo, AR Radin, V Kamat, A Badithe, LH Ben, BL Bennett, S Zhong, ...
Nature communications 9 (1), 1421, 2018
2042018
Activin A more prominently regulates muscle mass in primates than does GDF8
E Latres, J Mastaitis, W Fury, L Miloscio, J Trejos, J Pangilinan, ...
Nature communications 8 (1), 15153, 2017
1662017
Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates
KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ...
The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018
1592018
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
E Latres, J Pangilinan, L Miloscio, R Bauerlein, E Na, TB Potocky, ...
Skeletal muscle 5, 1-13, 2015
1422015
Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice
E Burova, A Hermann, J Waite, T Potocky, V Lai, S Hong, M Liu, ...
Molecular cancer therapeutics 16 (5), 861-870, 2017
1412017
Bispecific antibodies and antibody–drug conjugates (ADCs) bridging HER2 and prolactin receptor improve efficacy of HER2 ADCs
J Andreev, N Thambi, AE Perez Bay, F Delfino, J Martin, MP Kelly, ...
Molecular cancer therapeutics 16 (4), 681-693, 2017
1392017
A global benchmark study using affinity-based biosensors
RL Rich, GA Papalia, PJ Flynn, J Furneisen, J Quinn, JS Klein, ...
Analytical biochemistry 386 (2), 194-216, 2009
1242009
High affinity human antibodies to human IL-4 receptor
S Stevens, TT Huang, JH Martin, JL Fairhurst, A Rafique, M Torres, ...
US Patent 7,605,237, 2009
1222009
Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions
V Kamat, A Rafique
Analytical biochemistry 536, 16-31, 2017
1092017
Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology
MJ Cannon, GA Papalia, I Navratilova, RJ Fisher, LR Roberts, KM Worthy, ...
Analytical biochemistry 330 (1), 98-113, 2004
1022004
Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys
H Okamoto, J Kim, JP Aglione, J Lee, K Cavino, E Na, A Rafique, JH Kim, ...
Endocrinology 156 (8), 2781-2794, 2015
962015
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
D Skokos, JC Waite, L Haber, A Crawford, A Hermann, E Ullman, R Slim, ...
Science translational medicine 12 (525), eaaw7888, 2020
892020
系统目前无法执行此操作,请稍后再试。
文章 1–20